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Treatments with nonsteroidal anti-inflammatory drugs (NSAIDs) have increased the 
number of patients with gastrointestinal complications. Qing Dai has been 
traditionally used in Chinese herbal medicine for various inflammatory diseases such 
as ulcerative colitis. We previously reported that Qing Dai suppressed inflammations 
by scavenging reactive oxygen species (ROS) in ulcerative colitis patients. Thus, Qing 
Dai can attenuate the production of ROS, which play an important role in NSAID-
induced gastrointestinal injuries. In this study, we aimed to elucidate whether Qing 
Dai decreased mitochondrial ROS production in NSAID-treated gastrointestinal cells 
by examining cellular injury, mitochondrial membrane potentials, and ROS 
production with specific fluorescent indicators. We also performed electron 
paramagnetic resonance measurement in isolated mitochondria with a spin-trapping 
reagent (CYPMPO or DMPO). Treatments with indomethacin and aspirin induced 
cellular injury and mitochondrial impairment in the gastrointestinal cells. Under 
these conditions, mitochondrial alterations were observed on electron microscopy. 
Qing Dai prevented these complications by suppressing ROS production in 
gastrointestinal cells. These results indicate that Qing Dai attenuated the ROS 
production from the NSAID-induced mitochondrial alteration in the gastrointestinal 
epithelial cells. Qing Dai treatment may be considered effective for the prevention 
NSAID-induced gastrointestinal injury. 
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Nonsteroidal anti-inflammatory drugs (NSAIDs), including low-dose aspirins, are the
most commonly prescribed drugs for arthritis, inflammation, and cardiovascular diseases.(1) 
However, the fact that NSAIDs often cause gastrointestinal (GI) complications cannot be 
ignored.(2,3) These complications originate from gastroduodenal ulcers and intestinal 
mucosal injury.(4) With the increasing number of elderly patients who are continuously 
treated with NSAIDs, the number of cases of severe hemorrhagic GI bleeding has also been 
increasing.(5,6) 
The pathogenesis of the aforementioned complications has been mostly ascribed to 
the mechanism of action of NSAIDs that induce cyclooxygenase (COX) inhibition and 
subsequent prostaglandin (PG) deficiency.(7) In addition to inhibiting cyclooxygenase and 
decreasing prostaglandin production, NSAIDs induce mucosal damage via reactive oxygen 
species (ROS). ROS-mediated mitochondrial damage as well as lipid, protein, and DNA 
oxidation lead to apoptosis and mucosal injury.(8) Of note, NSAIDs have been also reported 
to cause cellular injury independent of COX inhibition and PG deficiency.(9,10) We have 
reported that NSAIDs caused cellular lipid peroxidation and apoptosis with the production 
of ROS, mainly superoxide (O2•−).(11-13) O2•− is generated because of mitochondrial damage 
and decreases in mitochondrial membrane potentials (MTPs). In fact, NSAIDs were 
demonstrated to cause mitochondrial damage.(13) In addition, manganese superoxide 
dismutase (MnSOD), which is an antioxidant for O2•− in mitochondria, protects from 
NSAID-induced cell injury.(12) Thus, NSAID-induced complications can be suppressed by 
scavenging mitochondrial ROS. 
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Qing Dai is a navy dye extracted from Corculum cardissa. It contains natural 
ingredients such as indigo, indirubin, isoindigotin, and nimbosterol. Qing Dai has 
traditionally been used in Chinese herbal medicines for various inflammatory diseases.(14) 
For example, Qing Dai suppressed inflammation by scavenging ROS in ulcerative colitis 
patients.(15) The ingredients of Qing Dai seem to play an important role as ROS 
scavengers.(16) Herein, we hypothesized that Qing Dai should effectively prevent GI injury 
after NSAID treatment by inhibiting mitochondrial damage and ROS production. In this 
study, we investigated the protective effect of Qing Dai against NSAID-induced injury in 
gastric and small intestinal epithelial cells, RGM1 and IEC6, by exposing the cells to 
NSAIDs with Qing Dai pretreatment. 
 
Materials and Methods 
 
Materials. Indomethacin (IND) and acetylsalicylic acid (ASA) were obtained from 
Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Aminophenyl fluorescein (APF; 
Sekisui Medical Co., Ltd., Tokyo, Japan), 2-[5,5-dimethyl-2-oxo-2λ5-
(1,3,2)dioxaphosphinan-2-yl]-2-methyl-3,4-dihydro-2H-pyrrole 1-oxide (Radical Research 
Inc., Tokyo, Japan), β-nicotinamide adenine dinucleotide (NADH; Sigma-Aldrich, St. 
Louis, MO), D-glutamic acid (Sigma-Aldrich), malic acid (Wako Pure Chemical Industries, 
Ltd.), succinic acid (Sigma-Aldrich), Cell Counting Kit-8 (Dojindo, Kumamoto, Japan), 
MitoRed (Dojindo), MitoSOX (Life Technologies Inc., Gaithersburg, MD), and 
MITOISO2 mitochondria isolation kit (Sigma-Aldrich) were purchased. Qing Dai powder 
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was purchased from Seishinshoyakudo (Tokyo, Japan), a company that imports Qing Dai 
from China. The Qing Dai powder was dissolved in dimethyl sulfoxide (DMSO) at a 
proportion of 1:10 (w/v), sterilized by filtration (pore size, 0.2 µm), and stored at −20C for 
subsequent bioassay testing. All experiments, we used 0.1% DMSO-contained medium 
with or without reagent such as Qing Dai. The concentration of IND or ASA was adjusted 
according to that reported in previous studies.(1) 
Cell culture. The rat gastric epithelial cell line RGM1 and rat small intestinal 
epithelial cell line IEC6 were obtained from RIKEN BioResource Center (Ibaraki, Japan). 
RGM1 cells were grown in a 1:1 mixture of Dulbecco’s modified Eagle’s medium 
(DMEM) and Ham’s F-12 medium (Cosmo Bio, Tokyo, Japan) supplemented with 
inactivated 10% fetal calf serum (FCS; Gibco, Grand Island, NY) and 2 mM glutamine. 
IEC6 cells were grown in DMEM supplemented with 10% FCS and 4-μg/ml insulin. The 
cells were grown at 37°C in a humidified incubator with 5% CO2. 
Cell viability test by WST assay. Cell viability was examined using the Cell 
Counting Kit-8, according to the manufacturer’s instructions and previous reports.(3) Cells 
were dispersed in the 96-well dish at 10,000 cells/well and were incubated overnight. The 
cells were pretreated with Qing Dai (0, 1.25, 2.5, and 5 μg/ml) for 1 h, washed with 
phosphate-buffered saline (PBS; Life Technologies Inc.), and then treated with IND or 
ASA for 18 h. RGM1 cells were treated with 1 mM IND or 10 mM ASA, and IEC6 cells 
were treated with 2 mM IND or 20 mM ASA. After the treatments, the medium was 
replaced with a medium containing 100 μl of 10% WST-8. The cells were further incubated 
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for 1 h. The absorbance of each well at 450 nm was measured using a Varioskan plate 
reader (Thermo Fisher Scientific K. K., Kanagawa, Japan). 
Intracellular ROS determination by APF assay. Free radicals (hydroxyl 
radical and peroxynitrite) were detected by APF assay. Cells were treated with IND or ASA 
for 1 h after pretreatment with 5-µg/ml Qing Dai for 1 h. APF was diluted with PBS, in 
which the cells were incubated for 30 min at the concentration of 1 μM. After incubation, 
the cells were washed using a cold PBS twice. The intensities of the APF fluorescence were 
measured using Varioskan at Ex. 490 nm and Em. 515 nm.  
Measurement of mitochondrial transmembrane potential. MTPs were 
measured with a cell membrane-permeable rhodamine-based dye, MitoRed. Cells were 
treated with IND or ASA for 1 h after pretreatment with 5-µg/ml Qing Dai for 1 h. Cellular 
fluorescent images were captured using a chilled charged-coupled device camera 
(AxioCam color, ZEISS, Oberkochen, Germany) mounted on an epifluorescence 
microscope (Axiovert135M, Zeiss) connected to an image analyzing system (Axio Vision, 
Zeiss). The fluorescence intensities were analyzed using ImageJ 1.42q. Detected 
fluorescence from MitoRed at excitation and emission wavelengths were 559 and 588 nm, 
respectively. 
Measurement of mitochondrial superoxide. Superoxide leakage from 
mitochondria was detected using a fluorescence indicator, MitoSOX. Cells were treated 
with IND or ASA for 1 h following pretreatment with 5-µg/ml Qing Dai for 1 h. The cells 
were incubated for 10 min in 5 μM MitoSOX diluted with Hanks’ balanced salt solution 
(HBSS). After incubation, the cells were washed three times with a HBSS. Fluorescence 
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images at Ex. 510 nm and Em. 580 nm were captured with the same protocol as that of the 
study using MitoRed. The fluorescence intensities were analyzed using ImageJ 1.42q. 
Electron spin resonance spectroscopy. Isolated mitochondria were prepared 
from RGM1 cells with MITOISO2, according to the manufacture’s instruction and as 
reported previously.(1,4) The mitochondrial pellet was suspended and treated with 1 mM 
IND/2 mM aspirin for 1 h after pretreatment with 5-µg/ml Qing Dai for 1 h. After 
incubation, the mitochondrial pellet was suspended with a respiratory solution (5 mM 
succinate, 5 mM glutamate, 5 mM malate, and 5 mM NADH) containing a spin-trapping 
agent, either 10 mM CYPMPO or 20 mM DMPO. The solution was immediately 
transferred to a quartz flat cell (60 × 6 × 0.3 mm; RDC-60, Radical Research). The protein 
concentration in the final reaction mixture was 250 μg/ml, as evaluated using the above-
mentioned method (Bio-Rad Laboratories, Hercules, CA). The electron spin resonance 
(ESR) spectra were recorded using a JEOL-TE X-band spectrometer (JEOL, Tokyo, Japan). 
All ESR spectra were obtained under the following conditions: 10-mW incident microwave 
power, 100-kHz modulation frequency, 0.1-mT field modulation amplitude, and 15-mT 
scan range. Analysis of the hyperfine splitting constants and spectral computer simulation 
were performed using a Win-Rad Radical Analyzer System (Radical Research). All ESR 
spectra shown are representative of at least three independent experiments. 
Observation of mitochondria by electron microscopy. RGM-1 cells were 
treated with IND for 1 h after pretreatment with 5-µg/ml Qing Dai for 1 h. The cultures 
were fixed with 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Thereafter, the cells 
were postfixed for 2 h in cold-buffered, 1% OsO4 after experimental manipulations and 
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were dehydrated in a graded series of ethanol and propylene oxide, and were embedded in 
Epon. Epon sections were cut on the Reichert-Jung ultramicrotome, were stained with 
uranyl acetate and lead citrate, and were then imaged under a Hitachi (H-7000) electron 
microscope. 
Statistical analysis. The statistical significances were evaluated using analysis of 
variance followed by the Tukey test for honestly significant difference. A p<0.05 was 
considered significant. 
 
Results 
 
Qing Dai partially prevented cellular injury by IND or aspirin treatment 
in the gastric and small intestinal epithelial cells. To examine the protective effect 
of Qing Dai against IND- or ASA-induced cellular damage, we performed a cell viability 
assay in gastric epithelial RGM1 cells and small intestinal epithelial IEC6 cells. Figure 1 
shows the protective effect of Qing Dai. The exposure of RGM1 and IEC6 cells to IND or 
ASA for 18 h caused a significant loss of cell viability. IND and ASA induced twice more 
cell death in RGM1 than that in IEC6. However, pretreatment with Qing Dai for 1 h before 
the IND or ASA treatment significantly prevented viability loss. The pretreatment with 
Qing Dai reduced cytotoxicity in a dose-dependent manner (1.25, 2.5, and 5 μg/ml). In 
addition, Figure 2 shows the determination of intracellular ROS by APF assay. Although 
the IND or ASA treatment increased the fluorescence intensity of APF, Qing Dai reduced 
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the fluorescence intensity. These results indicate that Qing Dai had a protective effect 
against IND- or ASA-induced cellular damage by inhibiting ROS production. 
Qing Dai attenuated mitochondrial impairment induced by IND or ASA 
in the gastric and small intestinal epithelial cells. In a previous study, we 
demonstrated that mitochondrial transmembrane potential was reduced by exposing gastric 
and small intestinal cells to IND or ASA.(1,5) To examine the protective effect of Qing Dai 
against IND- or ASA-induced mitochondrial transmembrane potential, we investigated 
transmembrane potentials with the fluorescent indicator MitoRed. The fluorescence 
intensity of this dye depends on MTPs, and this dye can be used as an indicator of 
mitochondrial damage. Figure 3 shows that the fluorescence intensity of MitoRed in 
untreated cells was significantly greater than that in Qing Dai-treated cells. These data 
indicate that Qing Dai has a protective effect on the mitochondria. 
Qing Dai partially prevented IND/ASA-induced cellular ROS. We 
demonstrated that the disruption of MTP by IND/ASA treatment is accompanied with the 
release of ROS, particularly superoxide leakage from mitochondria. To examine whether 
the pretreatment of Qing Dai decreases IND/ASA-induced mitochondrial ROS production, 
we treated gastric and small intestinal cells with IND/ASA, with or without Qing Dai 
pretreatment. Figure 4 shows the fluorescence intensity of MitoSOX. MitoSOX permeates 
live cells, where it selectively targets mitochondria and is rapidly oxidized by O2•−, but not 
by other ROS and reactive nitrogen species. The result shows that the MitoSOX 
fluorescence intensities of the IND/ASA-treated cells with Qing Dai pretreatment were 
significantly decreased compared with those of the nonpretreated cells. These results 
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indicate that the Qing Dai treatment inhibited IND/ASA-induced ROS production in 
mitochondria. We also performed EPR spectroscopy of isolated mitochondrial fraction in 
gastric RGM1 cells using a spin-trapping reagent, either DMPO or CYPMPO (Fig. 5). The 
reduction in the signal intensity of DMPO-OH/CYPMPO-OOH reflected the hydroxyl 
radical and superoxide scavenging ability of Qing Dai. These results strongly suggest that 
the Qing Dai treatment prevented IND/ASA-induced cellular injury by reducing the 
production of ROS in the GI cells. 
Qing Dai attenuated mitochondrial swelling induced by IND in the 
RGM1 cells. To examine the mitochondrial damage by IND exposure and the efficacy of 
Qing Dai pretreatment, the ultrastructure of RGM-1 cells after experimental manipulations 
were examined with an electron microscope. The control cells showed normal-shaped 
mitochondria, numerous round or oval shapes, and some rough endoplasmic reticula in the 
cytoplasm (Fig. 6a and 6d). The IND-treated cells displayed disorganized and swollen 
mitochondria with ruptured or disappearing swollen rough endoplasmic reticula and 
highly visible vacuoles (Fig. 6b and 6e). The RGM1 cells with Qing Dai pretreatment 
significantly ameliorated these pathological changes (Fig. 6c and 6f). 
 
Discussion 
 
In this study, we demonstrated for the first time that Qing Dai attenuates NSAID-
induced cellular injury by protecting mitochondria in GI epithelial cells. NSAIDs induced a 
disease condition with ROS production.(13) Qing Dai is likely to provide clinical benefits as 
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an antioxidant. The anti-inflammatory effect of Qing Dai is thought to inhibit an immune 
reaction such as O2•− generation and elastase release by neutrophils.(16) The present study 
demonstrated that Qing Dai treatment directly decreases IND/ASA-induced O2•− and 
hydroxyl radical productions in GI cells (Fig. 2 and 5). As shown in Fig. 1, the Qing Dai 
treatment attenuated NSAID-induced cell death. Through its mitochondrial protective effect 
(Fig. 3 and 6), Qing Dai suppressed NSAID-induced cellular ROS production (Fig. 2, 4, 
and 5), resulting in cell survival. In addition, Qing Dai directly scavenged for ROS.(15) 
Considering these data, Qing Dai treatment should suppress NSAID-induced side effects at 
the molecular, cellular, and tissue levels. 
In this study, the Qing Dai treatment ameliorated the pathological mitochondrial 
alteration in the GI cells (Fig. 3 and 6). The alteration is induced by ROS in several cells 
such as brain astrocyte and breast cancer cells with the structural destruction of 
mitochondria.(17,18) Thus, Figure 6 indicated that Qing Dai protected cells through 
protection of mitochondria by scavenging ROS. This alteration occurs most likely because 
of mitochondrial ROS production (Fig. 5). Mitochondrial ROS regulates apoptosis 
induction by completely activating the caspase cascade.(17) For instance, tumor necrosis 
factor (TNF) induces apoptosis via the production of mitochondrial ROS with its 
alteration.(20,21) Of note, N-acetylcysteine inhibits TNF-induced cell death.(22) Therefore, 
Qing Dai suppresses NSAID-induced death via mitochondrial protection in cells. The 
antioxidant in Qing Dai such as indigo possibly plays a role in its protective effect. Qing 
Dai includes 0.7% indigo, 0.4% indirubin and 0.04% tryptanthrin as major contents.(16) 
Indigo and indirubin are reported as a ROS scavenger for super oxide anion and hydroxyl 
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radical. These attenuate an inflammation in vivo by suppressing a production of 
inflammatory cytokine such as interferon- and interleukin-6.(23) Tryptantherin is COX-2 
inhibitor, which is also suggested to reduce an inflammation in vivo.(24) However, the 
effects are difficult to relate cytoprotection. Indigo and indirubin did not suppressed IND/ 
ASA-induced cell injury (supporting information Fig. S1). We also discuss how Qing Dai 
activates a cellular antioxidative system. 
In this study, we used NSAIDs to injure and to kill cells via both endoplasmic 
reticulum (ER) stresses and ROS production which is involved by electron transfer 
inhibition in mitochondria.(11) For cytoprotection from an exposure of NSAIDs, 
prostaglandins are effective because it act as an intrinsic electrophile which induces anti-
oxidative responsible proteins to reduce ROS.(11) In a cell, super oxide anion metabolized to 
peroxynitrite, which causes cell death with mitochondrial swelling and calcium release 
which involves ER stresses.(25) As the abovementioned, indigo and indirubin are a ROS 
scavenger. In fact, Figure 6 shows that Qing Dai protected the NSAIDs-induced 
mitochondrial alternation. Because IC50 of indigo and indirubin for scavenging super oxide 
anion are more than 30 M, the cytoprotection cannot be explained by only scavenging 
ROS with indigo and indirubin. Qing Dai in this study is estimated to include 26.7 nM 
indigo, 15.3 nM indirubin and 1.6 nM tryptantherin. Xanthine/Xanthine oxidase (X/XO)-
induced ROS were slightly scavenged by 10 µM of indigo or indirubin under cell-free 
condition (supporting information Fig. S2). This suggests that Qing Dai upregulates cellular 
antioxidative enzyme. In a cellular antioxidative system, mitochondria are protected from 
oxidative stress by MnSOD, a mitochondria-specific antioxidative enzyme.(26) MnSOD is 
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upregulated under various stress conditions such as exposures to ionizing radiation 
interferon-, proinflammatory cytokines, and NSAIDs.(27-29) Meanwhile we hypothesized 
that Qing Dai upregulates an expression of MnSOD, pretreatment with Qing Dai did not 
induce the expression of MnSOD protein, even at NSAID treatment (data not shown). This 
suggests that the pharmaceutical effect of Qing Dai is similar with that of MnSOD at a 
reaction. 
We propose that Qing Dai attenuates ROS production from NSAID-induced 
mitochondrial alteration in GI epithelial cells. Qing Dai should provide effective prevention 
against GI injury from NSAID treatment. 
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Fig1 
 
 
Fig. 1. Cell viability test using the WST assay. 
Indomethacin (IND)/aspirin (ASA)-induced cellular injury in the RGM1 (A) and IEC6 cells 
(B) was evaluated using the Cell Counting Kit-8. Data are expressed as percentages relative 
to untreated cells (mean ± SD). n = 4; * p<0.05, **p<0.01. 
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Fig2 
 
 
Fig. 2. Determination of intracellular ROS using the APF assay. 
Indomethacin (IND)/aspirin (ASA)-induced ROS in the RGM1 and IEC6 cells were 
determined. The cells were pretreated with Qing Dai at 0-5 µg/ml for 1 h and were then 
exposed to indomethacin or aspirin for 1 h. The graphs express the IND- or ASA-induced 
ROS in the RGM1 (A) and IEC6 cells (B). The data show the fluorescence intensity of APF 
(mean ± SD). Ex. 490 nm and Em. 515 nm. n = 4; * p<0.05, ** p<0.01. 
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Fig3 
 
 
Fig. 3. Determination of mitochondrial membrane potentials using MitoRed. 
Mitochondrial membrane potentials in the RGM1 and IEC6 cells were detected using 
MitoRed. RGM1 (A) and IEC6 cells (B) were pretreated for 1 h with 5-µg/ml Qing Dai and 
were then exposed for 1 h to indomethacin (IND) or aspirin (ASA). Ex. 559 nm and Em. 
588 nm. n = 5; * p<0.001. 
 
 
 
 
 
 
   
21 
 
 
Fig4 
 
 
Fig. 4. Determination of mitochondrial ROS using MitoSOX. 
Indomethacin (IND)- or aspirin (ASA)-induced mitochondrial ROS were determined by 
MitoSOX. RGM1 (A) and IEC6 cells (B) were pretreated for 1 h with 5-µg/ml Qing Dai 
and were then exposed for 1 h to indomethacin (IND) or aspirin (ASA). Ex. 510 nm and 
Em. 580 nm. n = 5; * p<0.001. 
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Fig5 
 
 
Fig. 5. Electron paramagnetic resonance (EPR) measurement using mitochondria. 
Indomethacin (IND)- or aspirin (ASA)-induced mitochondrial ROS were measured by EPR 
using isolated mitochondria. Isolated mitochondria were pretreated for 1 h with 5-µg/ml 
Qing Dai and were then exposed for 1 h to 1 mM IND or 10 mM ASA. ESR was measured 
in a respiration buffer containing a spin-trapping agent. CYPMPO was used as the spin-
trapping agent 
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Fig6 
 
 
Fig. 6. The effect of Qing Dai treatment on ultrastructural change in RGM1 cells exposed 
to indomethacin (IND). 
An electron microscopic image showing an ultrastructure of control (a), IND injury (b), and 
pretreatment with Qing Dai before IND injury (c). (d-f) Photographs with thrice the 
magnification of (a)-(c). Control cells showing normal-shaped mitochondria. The IND-
treated cells showed strongly deformed mitochondria. Pretreatment of Qing Dai inhibited 
mitochondrial swelling. Magnifications: (a) ×12000; (b) ×25000; (c) ×20000; (d) ×36000; 
(e) ×75000 and (f) ×60000. Scale bars: 1 µm. 
